Riva-Cal D400
Natural health product licensed in Canada
- Licence holder
- Laboratoire Riva Inc.
- NPN or DIN-HM
- 80065914
- Status
- Active licence
- Licence date
- 15 December 2015
- Revision date
- 28 June 2017
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Calcium Source : Carbonate de calcium | 500 milligramme | Not calculated |
| Vitamine D Source : Cholécalciférol | 400 UI | Not calculated |
Non-medicinal ingredients
Croscarmellose de sodium, Talc, ascorbate de sodium, Stéarate de magnésium, Cellulose microcristalline, Dioxyde de titane, Poly(éthylène glycol), Cire de Carnauba, Sucrose, Poly(alcool vinylique), dl-alpha tocophérol, FD&C Blue No.2 Aluminum Lake, Maltodextrine, Laque d'aluminium bleu FD&C n° 1, gomme acacia, Modified food starch, Dioxyde de silicium, Triglycérides à chaîne moyenne
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes, adolescents et enfants | minimum: 6 years | minimum: 1 Comprimé ; maximum: 2 Comprimé | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
A factor in the maintenance of good health. Vitamin D and Calcium helps in the development and maintenance of bones and teeth. Vitamin D helps in the absorption and use of calcium and phosphorus and helps to prevent vitamin D deficiency. Calcium intake, when combined with sufficient Vitamin D, a healthy diet and regular exercise may reduce the risk of developing osteoporosis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80065914
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2017. Photograph the packaging to check whether it has changed. Photograph the packaging